As Cyclosporine Options Grow, Focus Remains on the Vehicle

Amid a surge in dry eye cases since reopening her practice during the ongoing pandemic, Lisa Nijm, MD, JD, shares how cyclosporine, a well-established form of treatment, poses both challenges and advantages for ophthalmologists.

Source: https://www.ophthalmologytimes.com/view/as-cyclosporine-options-grow-focus-remains-on-vehicle

The Ophthalmologist: Clinical and Therapeutic Journal is an open access, peer-reviewed, academic journal which has a wide range of fields which creates a platform for the authors to publish a relatively reliable source of information on recent technology, review articles, original articles etc. and provides free online access to the researchers worldwide. The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication. A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be uploaded directly through mail id: ophthalmologist@eclinicalsci.com

Online Submission: https://www.pulsus.com/submissions/ophthalmologist-clinical-therapeutic-journal.html

Media Contact
Sarah Rose
Journal Manager
The Ophthalmologist: Clinical and Therapeutic Journal
Email: ophthalmologist@eclinicalsci.com